Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc. | Director | Common Stock | 24.9K | $799K | $32.03 | Jun 14, 2024 | Via Alma Life Sciences, LLC |
Arcturus Therapeutics Holdings Inc. | Director | Common Stock | 3.13K | $100K | $32.03 | Jun 14, 2024 | Direct |
Immix Biopharma, Inc. | Director | Common Stock | 46.1K | $98.2K | $2.13 | Jun 11, 2024 | Direct |
ANAPTYSBIO, INC | Director | Common Stock | 3.9K | $90.3K | $23.16 | Jun 15, 2024 | Direct |
Immix Biopharma, Inc. | Director | Common Stock | 20K | $42.6K | $2.13 | Jun 11, 2024 | Via ALMA Life Sciences, LLC |
ANAPTYSBIO, INC | Director | Restricted Stock Unit | 0 | $0 | $23.16 | Jun 15, 2024 | Direct |
Arcturus Therapeutics Holdings Inc. | Director | Deferred Stock Units | 0 | $0 | $32.03 | Jun 14, 2024 | Direct |
Transcode Therapeutics, Inc. | Director | Stock Option (right to buy) | 70K | Jun 14, 2024 | Direct | ||
Immix Biopharma, Inc. | Director | Stock Option (Right to Buy) | 33K | Jun 11, 2024 | Direct | ||
ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 16.5K | Jan 3, 2024 | Direct | ||
Arcturus Therapeutics Holdings Inc. | Director | Stock option (right to buy) | 15K | Jun 14, 2024 | Direct |